Pancreatic involvement in Japanese patients with von Hippel-Lindau disease: results of a nationwide survey

详细信息    查看全文

• 作者：Hisato Igarashi (1)
  Tetsuhide Ito (1)
  Isao Nishimori (2)
  Kenji Tamura (4)
  Ichiro Yamasaki (4)
  Masao Tanaka (3)
  Taro Shuin (4)
  
• 关键词：Pancreas ; von Hippel ; Lindau disease ; Neuroendocrine tumor ; Pancreatic cystic tumor
• 刊名：Journal of Gastroenterology
• 出版年：2014
• 出版时间：March 2014
• 年：2014
• 卷：49
• 期：3
• 页码：511-516
• 全文大小：266 KB
• 参考文献：1. Latif F, Tory K, Gnarra J, Yao M, Duh FM, Orcutt ML, et al. Identification of the von Hippel-Lindau disease tumor suppressor gene. Science. 1993;260:1317-0. CrossRef
  2. Lonser RR, Glenn GM, Walther M, Chew EY, Libutti SK, Linehan WM, et al. von Hippel-Lindau disease. Lancet. 2003;361:2059-7. CrossRef
  3. Maher ER, Iselitus L, Yates JR, Littler M, Benjamin C, Harris R, et al. Von Hippel-Lindau disease: a genetic study. J Med Genet. 1991;28:443-. CrossRef
  4. Maddock IR, Moran A, Maher ER, Teare MD, Norman A, Payne SJ, et al. A genetic register for von Hippel-Lindau disease. J Med Genet. 1996;33:120-. CrossRef
  5. Hough DM, Stephens DH, Johnson CD, Binkovitz LA. Pancreatic lesions in von Hippel-Lindau disease: prevalence, clinical significance, and CT findings. Am J Roentgenol. 1994;162:1091-. CrossRef
  6. Hammel PR, Vilgrain V, Terris B, Penfomis A, Sauvanet A, Correas JM, et al. Pancreatic involvement in von Hippel-Lindau disease. The Groupe Francophone d’Etude de la Maladie de von Hippel–Lindau. Gastroenterology. 2000;119:1087-5. CrossRef
  7. Neumann HP, Dinkel E, Brambs H, Wimmer B, Friedburg H, Volk B, et al. Pancreatic lesions in the von Hippel-Lindau syndrome. Gastroenterology. 1991;101:465-1.
  8. Kanno A, Satoh K, Hamada S, Hirota M, Masamune A, Motoi F, et al. Serous cystic neoplasm of the whole pancreas in a patient with von Hippel-Lindau disease. Intern Med. 2011;50:1293-. CrossRef
  9. Binkovitz LA, Johnson CD, Stephens DH. Islet cell tumors in von Hippel-Lindau disease: increased prevalence and relationship to the multiple endocrine neoplasms. Am J Roentgenol. 1990;155:501-. CrossRef
  10. Charlesworth M, Verbeke CS, Falk GA, Walsh M, Smith AM, Morris-Stiff G. Pancreatic lesions in von Hippel-Lindau disease? A systemic review and meta-synthesis of the literature. J Gastrointest Surg. 2012;16:1422-.
  11. Tamura K, Nishimori I, Ito T, Yamasaki I, Igarashi H, Shuin T. Diagnosis and management of pancreatic tumor in von Hippel-Lindau disease. World J Gastroenterol. 2010;16:4515-. CrossRef
  12. Yamasaki I, Nishimori I, Ashida S, Kohsaki T, Onishi S, Shuin T. Clinical characteristics of pancreatic neuroendocrine tumors in Japanese patients with von Hippel-Lindau disease. Pancreas. 2006;33:382-. CrossRef
  13. Cheng TY, Su CH, Shyr YM, Lui WY. Management of pancreatic lesions in von Hippel-Lindau disease. World J Surg. 1997;21:301-2. CrossRef
  14. Libutti SK, Choyke PL, Bartlett DL, Vargas H, Walther M, Lubensky I, et al. Pancreatic neuroendocrine tumors associated with von Hippel-Lindau disease: diagnostic and management recommendations. Surgery. 1998;124:1153-. CrossRef
  15. Libutti SK, Choyke PL, Alexander HR, Glenn G, Bartlett DL, Zbar B, et al. Clinical and genetic analysis of patients with pancreatic neuroendocrine tumors associated with von Hippel-Lindau disease. Surgery. 2000;128:1022-. Discussion 1027-. CrossRef
  16. Mukhopadhyay B, Sahdev A, Monson JP, Besser GM, Reznek RH, Chew SL. Pancreatic lesions in von Hippel-Lindau disease. Clin Endocrinol (Oxf). 2002;57:603-. CrossRef
  17. Delman KA, Shapiro SE, Jonasch EW, Lee JE, Curley SA, Evans DB, et al. Abdominal visceral lesions in von Hippel-Lindau disease: incidence and clinical behavior of pancreatic and adrenal lesions at a single center. World J Surg. 2006;30:665-. CrossRef
  18. Blansfield JA, Choyke L, Morita SY, Choyke PL, Pingpank JF, Alexander HR, et al. Clinical, genetic and radiographic analysis of 108 patients with von Hippel-Lindau disease (VHL) manifested by pancreatic neuroendocrine neoplasms (PNETs). Surgery. 2007;142:814-. Discussion 818.e1-.
  19. Lee KH, Lee JS, Kim BJ, Lee JK, Kim SH, Kim SH, et al. Pancreatic involvement in Korean patients with von Hippel-Lindau disease. J Gastroenterol. 2009;44:447-2. CrossRef
  20. NCCN Clinical Practice Guidelines in Oncology (NCCN guidelines?. Neuroendocrine tumors, version I. 2011. NCCN.org. National Comprehensive Cancer Network, Inc. 2011.
  21. Maher ER, Neumann HP, Richard S. von Hippel-Lindau disease: a clinical and scientific review. Eur J Hum Genet. 2011;19:617-3. CrossRef
  22. Yao JC, Hassan M, Phan A, Dagohoy C, Leary C, Mares JE, et al. One hundred years after “carcinoid- epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol. 2008;26:3063-2. CrossRef
  23. Ito T, Sasano H, Tanaka M, Osamura RY, Sasaki I, Kimura W, et al. Epidemiological study of gastroenteropancreatic neuroendocrine tumors in Japan. J Gastroenterol. 2010;45:234-3. CrossRef
  24. Yao JC, Shah MH, Ito T, Bohas CL, Wolin EM, Van Cutsem E, et al. Everolimus for advanced pancreatic neuroendocrine tumors. N Engl J Med. 2011;364:514-3. CrossRef
  25. Raymond E, Dahan L, Raoul JL, Bang YJ, Borbath I, Lombard-Bohas C, et al. Sunitinib malate for the treatment of pancreatic neuroendocrine tumors. N Engl J Med. 2011;364:501-3. CrossRef
  
• 作者单位：Hisato Igarashi (1)
  Tetsuhide Ito (1)
  Isao Nishimori (2)
  Kenji Tamura (4)
  Ichiro Yamasaki (4)
  Masao Tanaka (3)
  Taro Shuin (4)
  
  1. Department of Medicine and Bioreguratory Science, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan
  2. Nishimori Clinic, Nakagami, 49-4, Sakawa, Kochi, 789-1233, Japan
  4. Department of Urology, Kochi Medical School, Nankoku, Kochi, 783-8505, Japan
  3. Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan
  
• ISSN：1435-5922

文摘

Background The frequency and prognosis of pancreatic endocrine tumors (PNET)/pancreatic cystic tumors (PCT) in Japanese patients with von Hippel-Lindau disease (VHL) are still open to question. Methods We conducted the first nationwide epidemiological study of VHL disease in Japan to elucidate this question. Data on 377 VHL patients (PNET, 53; PCT, 152) were reported, and then their clinical characteristics were analyzed. Results PNET was found in 14.1?% and PCT in 40.3?%; 4.5?% had both. The onset of PNET and PCT mostly occurred at 30-9?years of age (median ages, 34 and 33?years, respectively). Metastasis was observed in 7.5?% of PNET patients at diagnosis, and 64.2?% underwent surgery including enucleation, partial and total pancreatectomy, and bypass surgery. Two patients received non-surgical therapies. No PNET-related deaths were observed. In PCT patients, no metastasis was observed at diagnosis, and 9.2?% underwent surgery or drainage. According to the classification system without or with adrenal pheochromocytoma, the VHL patients studied herein were subdivided into 313 (83?%) with VHL type 1 and 64 (17?%) with VHL type 2; 29 (9.3?%) and 24 (37.5?%) patients had PNET with VHL type 1 and 2, suggesting that patients with VHL type 2 were significantly more related to PNET than those with VHL type 1 (P?<?0.01). Conclusions This study showed no significant difference in the epidemiology of pancreatic involvement between Japanese and non-Japanese VHL patients. Concerning the prognosis, follow-up study is needed.